FDA Inspection 915249 — Carter BloodCare - Texoma
The FDA completed an inspection of Carter BloodCare - Texoma on February 20, 2015 in Sherman, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 20, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sherman, TX (United States)